Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Water below half by mass
What ifWhat if the nicotine liquid contained 40 wt. % water and used propylene glycol as the main carrier?
Claim language“water in an amount of at least 50 wt. %”
Water dissolves nicotine lactate, and propylene glycol mixes with the aqueous solution to form a single liquid phase. A wick feeds the mixture to a resistive heater, and the emitted vapor cools into droplets in the airflow.
1.1Inorganic acid sets acidity
What ifWhat if dilute hydrochloric acid supplied the protons for nicotine salt formation?
Claim language“one or more organic acids”
Dilute hydrochloric acid protonates dissolved nicotine free base in water, leaving chloride as the counterion. A metering pump adds acid during mixing until a pH electrode registers the formulation set point.
1.1Acetic acid supplies acetate
What ifWhat if acetic acid supplied the counterion for protonated nicotine in the aqueous liquid?
Claim language“lactic acid or a salt thereof”
A metering pump adds diluted acetic acid to nicotine free base in a stirred water vessel. Proton transfer produces dissolved protonated nicotine and acetate, and a pH electrode monitors the mixture during acid addition.
1.1Oxygen control through packaging
What ifWhat if a nitrogen flush and a sealed collapsible pouch controlled oxygen exposure?
Claim language“ascorbic acid or a salt thereof”
A nitrogen flush displaces air from the pouch before filling with an aqueous nicotine lactate solution. The low-permeability pouch collapses as liquid leaves, so dispensing draws little fresh air into the reservoir.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Sampling for occupational exposure studies
A push-mode ejector draws aqueous nicotine solution containing lactate from a sealed cartridge and discharges droplets into a closed exposure-test duct. A flow controller supplies dilution air upstream of a sampling section. A pump draws a measured air volume through a filter and a downstream sorbent tube, which are analyzed separately for particle-phase and vapor-phase nicotine.
Component substitution
Vibrating mesh in place of push ejector
An annular piezoelectric actuator bonded to a perforated metal membrane replaces the push-mode ejector. A porous wick feeds aqueous nicotine and lactate solution from a vented reservoir to the liquid-facing side of the membrane. An alternating drive voltage at the membrane's loaded resonance vibrates the mesh and ejects droplets through its perforations into an air passage.
Parameter or scale variation
Parallel ejectors for higher liquid throughput
A bench assembly distributes aqueous nicotine and lactate solution from one reservoir to four push-mode ejectors through branches with matched flow restrictions. Each ejector runs at 100 pulses per second, and the controller offsets adjacent pulse trains by 2.5 milliseconds. The four outlets discharge into a shared collection chamber at an aggregate rate of 400 ejection pulses per second.
Timed bursts for transient aerosol measurements
A controller drives a cartridge-fed push-mode ejector containing aqueous nicotine and lactate solution at 200 pulses per second for 250 milliseconds, followed by a 750-millisecond idle interval. Carrier air flows continuously through the collection chamber during both intervals. A trigger output marks the start of each 50-pulse burst so a downstream optical detector records the rise and decay of the aerosol signal.
Combination with existing systems
Droplet delivery with cascade impactor sampling
A cartridge containing aqueous nicotine and lactate solution feeds a push-mode ejector mounted at the inlet of a cascade impactor. A downstream pump draws carrier air through the ejector chamber and the impactor at the flow used to calibrate the stage cutoffs. Liquid chromatography measures nicotine recovered from each stage, and the cumulative mass distribution gives the aerodynamic diameter below which half the recovered nicotine mass collects.
Automated or data-driven variant
Optical feedback for missed ejection pulses
A push-mode ejector supplied with aqueous nicotine and lactate solution fires across a light beam focused near the nozzle. A photodiode and a controller measure the light transient in a timed window after each drive pulse. The controller counts pulses without a transient and suspends firing when three consecutive pulses produce no detected droplets.
Specific version of a part
High water nicotine lactate
Purified water makes up at least 95 wt. % of the final liquid. Mixing nicotine free base with lactic acid in the water produces dissolved protonated nicotine with lactate as the counterion.
Citrate and ascorbic acid mixture
Purified water makes up 98 wt. % of the final batch, with nicotine, citric acid, and ascorbic acid making up the balance. The acids dissolve under stirring before nicotine free base is added, and a pH electrode monitors the mixture as the nicotine dissolves.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1nicotine or a salt thereof, water in an amount of at least 50 wt. %, and one or more organic acids comprising lactic acid or a salt thereof, ascorbic acid or a salt thereof, citric acid or a salt thereof, or a combination thereof.
Thus, in the presence of water as a solvent, formation of a salty GAA citrate takes place. Water enables proton transition from citric acid to GAA.
A · US 2012/0238629 A1 · ¶ 84
In another aspect, an orally inhalable nicotine formulation is provided comprising nicotine, or a pharmaceutically acceptable salt thereof, a monohydric alcohol in an amount of 6-12% by wt of the formulation, lactic acid in an amount of 0.4-0.6:1 nicotine by wt, menthol in an amount of 1-2:1 nicotine by wt and a propellant.
B · US 2021/0368853 A1 · ¶ 28
An empty cell means only that no passage was reproduced there.
Statements in these documents
They have improved physiological and therapeutic properties and are suitable for use as food supplements, animal feeds and in cosmetic or dermatological preparations in which especially their marked stability and good bioavailability of the addition compounds come to the fore.
A · US 2012/0238629 A1 · ¶ 1
The conversion to pure vegetarian diets led to losses in performance and; even after almost five years, the pure vegetarian diets are inferior to those containing animal proteins.
A · US 2012/0238629 A1 · ¶ 6
The present invention relates to inhalable formulations, and in particular, to novel inhalable formulations comprising nicotine for use in a standard pressurized metered dose inhaler for the purpose of tobacco cessation or tobacco harm reduction.
B · US 2021/0368853 A1 · ¶ 1
There remains an unmet need within the nicotine “vaping” industry to provide an aerosol with a more optimal set of physical characteristics which would allow provision of a very satisfying and immediate nicotine “hit” while avoiding excessive throat irritation and aversiveness including nausea at higher doses.
B · US 2021/0368853 A1 · ¶ 2
Cite aspatent.fyi, US 2026/0354440 A1, claim 1, first published 2026-11-18T23:03:08-05:00, https://patent.fyi/US20260354440/, SHA-256 ed727513ae2f874fa06d6a5e20611cfa43151e48c4164c1e587f77bc9a0c4e1d